Breastfeeding in women with systemic lupus erythematosus: results from a Norwegian quality register.
Journal
International breastfeeding journal
ISSN: 1746-4358
Titre abrégé: Int Breastfeed J
Pays: England
ID NLM: 101251562
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
received:
21
10
2022
accepted:
22
07
2023
medline:
3
8
2023
pubmed:
1
8
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Knowledge on breastfeeding among women with systemic lupus erythematosus (SLE) is sparse. We wanted to identify the frequency of breastfeeding in SLE, and to compare breastfeeding women with SLE to non-breastfeeding women to examine possible differences in disease characteristics and self-reported health data between the groups. Prospective data on women with SLE from RevNatus, a consent-based Norwegian nationwide quality register was used for this study. Data were collected during January 2016 to September 2021. We used data registered at inclusion when planning pregnancy or in 1 A total of 114 pregnancies in 101 SLE women were included in the analysis. A majority of the women (78%) breastfed six weeks postpartum. Six and 12 months after delivery, breastfeeding rates were 54% and 30% respectively. Six weeks postpartum, non-breastfeeding women showed higher prevalence of emergency caesarean delivery (p = 0.038), preeclampsia (p = 0.056) and lower educational level (p = 0.046) compared to breastfeeding women. 12 months after delivery, we observed a higher frequency of multiparity among breastfeeding women (p = 0.017) compared to non-breastfeeding. Overall, we found low disease activity in both groups at all registrations in the follow-up, and disease activity did not differ between the groups. More than 70% of both breastfeeding and non-breastfeeding women used hydroxychloroquine (HCQ). Breastfeeding rate in women with SLE was high six weeks postpartum. Multiparous women breastfed longer than primiparas. Disease activity, use of HCQ, and self-reported health data were comparable between the groups. Our data indicate that health professionals should encourage women with SLE to breastfeed.
Sections du résumé
BACKGROUND
Knowledge on breastfeeding among women with systemic lupus erythematosus (SLE) is sparse. We wanted to identify the frequency of breastfeeding in SLE, and to compare breastfeeding women with SLE to non-breastfeeding women to examine possible differences in disease characteristics and self-reported health data between the groups.
METHODS
Prospective data on women with SLE from RevNatus, a consent-based Norwegian nationwide quality register was used for this study. Data were collected during January 2016 to September 2021. We used data registered at inclusion when planning pregnancy or in 1
RESULTS
A total of 114 pregnancies in 101 SLE women were included in the analysis. A majority of the women (78%) breastfed six weeks postpartum. Six and 12 months after delivery, breastfeeding rates were 54% and 30% respectively. Six weeks postpartum, non-breastfeeding women showed higher prevalence of emergency caesarean delivery (p = 0.038), preeclampsia (p = 0.056) and lower educational level (p = 0.046) compared to breastfeeding women. 12 months after delivery, we observed a higher frequency of multiparity among breastfeeding women (p = 0.017) compared to non-breastfeeding. Overall, we found low disease activity in both groups at all registrations in the follow-up, and disease activity did not differ between the groups. More than 70% of both breastfeeding and non-breastfeeding women used hydroxychloroquine (HCQ).
CONCLUSIONS
Breastfeeding rate in women with SLE was high six weeks postpartum. Multiparous women breastfed longer than primiparas. Disease activity, use of HCQ, and self-reported health data were comparable between the groups. Our data indicate that health professionals should encourage women with SLE to breastfeed.
Identifiants
pubmed: 37525232
doi: 10.1186/s13006-023-00576-y
pii: 10.1186/s13006-023-00576-y
pmc: PMC10392016
doi:
Substances chimiques
Hydroxychloroquine
4QWG6N8QKH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Informations de copyright
© 2023. The Author(s).
Références
Acta Obstet Gynecol Scand. 2002 Sep;81(9):870-7
pubmed: 12225305
Rheumatol Int. 2017 Jul;37(7):1183-1186
pubmed: 28540416
Mod Rheumatol. 2021 Jan;31(1):20-28
pubmed: 32475188
Arthritis Rheum. 1992 Jun;35(6):630-40
pubmed: 1599520
Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):323
pubmed: 24518484
Arthritis Care Res (Hoboken). 2014 Nov;66(11):1718-24
pubmed: 24839126
Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv8-13
pubmed: 16980725
J Nutr. 2001 Nov;131(11):3012S-5S
pubmed: 11694638
Clin J Am Soc Nephrol. 2017 May 8;12(5):825-835
pubmed: 27821390
Arthritis Care Res (Hoboken). 2020 Apr;72(4):461-488
pubmed: 32090466
Lupus. 2004;13(9):679-82
pubmed: 15485102
Lupus. 2021 May;30(6):913-920
pubmed: 33611966
Breastfeed Med. 2020 Jul;15(7):443-452
pubmed: 32456452
Lupus. 2016 Aug;25(9):973-9
pubmed: 26888577
Breastfeed Med. 2015 Apr;10(3):156-62
pubmed: 25549051
Arch Gynecol Obstet. 2016 Feb;293(2):317-28
pubmed: 26112355
Public Health Nutr. 2003 Dec;6(8):773-83
pubmed: 14641948
Acta Obstet Gynecol Scand. 2015 Nov;94(11):1195-202
pubmed: 26234799
J Prenat Med. 2010 Oct;4(4):67-73
pubmed: 22439065
Arthritis Rheum. 2004 Feb 15;51(1):78-82
pubmed: 14872459
Arthritis Care Res (Hoboken). 2017 Aug;69(8):1201-1208
pubmed: 27696790
Front Immunol. 2016 Feb 08;7:35
pubmed: 26904025
Ann Rheum Dis. 2017 Mar;76(3):476-485
pubmed: 27457513
Orphanet J Rare Dis. 2006 Mar 27;1:6
pubmed: 16722594
Semin Respir Crit Care Med. 2014 Apr;35(2):249-54
pubmed: 24668539
Arthritis Res Ther. 2019 Nov 14;21(1):241
pubmed: 31727137